NCT01561768 - A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Influenza

Interventions

BIOLOGICAL

Novavax Quadrivalent vaccine

Quadrivalent VLP vaccine: low dose; intramuscular injection, deltoid

BIOLOGICAL

Novavax Quadrivalent vaccine

Quadrivalent VLP vaccine: medium dose; intramuscular injection, deltoid

BIOLOGICAL

Novavax Quadrivalent vaccine

Quadrivalent VLP vaccine: high dose; intramuscular injection, deltoid

BIOLOGICAL

Novavax Trivalent vaccine

Trivalent Dose; intramuscular injection, deltoid

BIOLOGICAL

cTIV

Preconfigured dose; intramuscular injection, deltoid

Trial Locations (4)

CMAX, Adelaide

Emeritus Research, Melbourne

Linear Clinical Research, Perth

Holdsworth House, Sydney